$102.90 +2.47 (%) Salix Pharmaceuticals Ltd - NASDAQ

Nov. 21, 2014 | 04:00 PM

Partner Headlines

  1. How Adam Feuerstein Follows The Biotech Sector

    Benzinga | Nov. 14, 2014 | 10:11AM EST
  2. Deutsche Bank Slashes Price Target On Salix Pharmaceuticals

    Benzinga | Nov. 10, 2014 | 10:04AM EST
  3. U.S. Produced Fewer Than Expected Jobs In October

    Benzinga | Nov. 9, 2014 | 20:16PM EST
  4. Health Sell-Offs Drag On IBD 50

    IBD | Nov. 7, 2014 | 18:32PM EST
  5. Dow, S&P 500 Flirt With Record, But Finish Just Off

    IBD | Nov. 7, 2014 | 16:28PM EST
  6. Stock Movers: Why Medicals Issues Are Dipping Today

    IBD | Nov. 7, 2014 | 15:26PM EST
  7. Mid-Afternoon Market Update: Lions Gate Surges On Earnings Beat; Abercrombie & Fitch Shares Decline

    Benzinga | Nov. 7, 2014 | 15:14PM EST
  8. Midday Losers From November 7: Roka Bioscience, Salix Pharmaceuticals, Intercept Pharmaceuticals, Extended Stay America

    Benzinga | Nov. 7, 2014 | 13:38PM EST
  9. Mid-Day Market Update: Allscripts Healthcare Slides On Downbeat Earnings; Sears Shares Climb

    Benzinga | Nov. 7, 2014 | 12:58PM EST
  10. Mid-Morning Market Update: Markets Edge Lower; Humana Profit Misses Estimates

    Benzinga | Nov. 7, 2014 | 12:22PM EST
  11. Jefferies Sees Acquisition Of Salix Pharmaceuticals As Being Even More Likely Now

    Benzinga | Nov. 7, 2014 | 10:39AM EST
  12. Morning Market Losers

    Benzinga | Nov. 7, 2014 | 09:58AM EST
  13. Benzinga's Top Downgrades

    Benzinga | Nov. 7, 2014 | 09:56AM EST
  14. Stocks Set For Higher Start After Mixed Jobs Report

    IBD | Nov. 7, 2014 | 09:01AM EST
  15. Stifel Nicolaus Downgrades Salix Pharmaceuticals To Hold

    Benzinga | Nov. 7, 2014 | 08:44AM EST
  16. Benzinga's Top #PreMarket Losers

    Benzinga | Nov. 7, 2014 | 08:22AM EST
  17. UPDATE: Stifel Downgrades Salix Pharmaceuticals As Uncovered Inventories Leaves Many Open Questions

    Benzinga | Nov. 7, 2014 | 08:15AM EST
  18. Salix Dives On Earnings, Probe; Akorn A Bad Seed Too

    IBD | Nov. 6, 2014 | 18:55PM EST
  19. Salix Dives On Miss, Probe

    IBD | Nov. 6, 2014 | 18:50PM EST
  20. Indexes Higher; El Pollo Loco Reports In Line

    IBD | Nov. 6, 2014 | 16:56PM EST
  21. Stocks Cling To Modest Gains; Advance Auto Rebounds

    IBD | Nov. 6, 2014 | 15:04PM EST
  22. Stocks Down As Early Gains Fade; Generac Dives, Tableau Soars

    IBD | Nov. 6, 2014 | 10:41AM EST
  23. Earnings Scheduled For November 6, 2014

    Benzinga | Nov. 6, 2014 | 05:42AM EST
  24. 3 IBD 50 Tech, Drug Stocks With Earnings Thursday

    IBD | Nov. 5, 2014 | 14:49PM EST
  25. Salix, Skyworks Lead 6 IBD50 EarningsReports On Tap

    IBD | Nov. 4, 2014 | 08:02AM EST
  26. Salix, Skyworks Lead 6 IBD 50 Earnings Reports On Tap

    IBD | Nov. 1, 2014 | 08:02AM EST
  27. Stocks Hold Near Session Highs; Drugmakers Shine Again

    IBD | Oct. 24, 2014 | 14:50PM EST
  28. Making Money With Charles Payne: 10/17/14

    FoxBusiness | Oct. 17, 2014 | 18:00PM EST
  29. Will Activis Win Competition For Allergan's Affection?

    Benzinga | Oct. 16, 2014 | 11:10AM EST
  30. AbbVie Board To Shareholders: Vote No On Shire Buy

    IBD | Oct. 16, 2014 | 00:52AM EST
  31. Shire Falls, AbbVie Questioned On Buyout Backtrack

    IBD | Oct. 15, 2014 | 13:11PM EST
  32. Stocks Dive, Then Pare Losses; Shire, Expedia, KeyCorp Crumble

    IBD | Oct. 15, 2014 | 10:37AM EST
  33. IBD 50: Medical, Internet Companies Top Q3 Estimates

    IBD | Oct. 13, 2014 | 19:15PM EST
  34. Patents, Taxes Lift Drug M&A

    IBD | Oct. 10, 2014 | 19:05PM EST
  35. IBD 50: Medical, Internet Companies Top Q3 Profit Estimates

    IBD | Oct. 10, 2014 | 18:45PM EST
  36. Drugmaker M&A Goes On, With Or Without Tax Inversions

    IBD | Oct. 10, 2014 | 17:37PM EST
  37. Allergan Steeply Raises Guidance, Taunts Valeant

    IBD | Oct. 9, 2014 | 11:56AM EST
  38. Salix, Actavis Among Big Cap Pharmas In Merger Mambo

    IBD | Oct. 7, 2014 | 19:33PM EST
  39. Salix Pharmaceuticals

    IBD | Oct. 7, 2014 | 18:59PM EST
  40. Actavis Finds Rx To Grow On Busy Drugmaker M&A Scene

    IBD | Oct. 7, 2014 | 18:33PM EST
  41. Progenics Receives $40M Milestone Following FDA Approval of RELISTOR For OIC Patients With Chronic Non-Cancer Pain

    Benzinga | Oct. 6, 2014 | 16:31PM EST
  42. Stocks Further Deteriorate; Salix Breaks Support

    IBD | Oct. 6, 2014 | 13:21PM EST
  43. Gilead Among Top IBD 50 Stocks Heading Into Earnings

    IBD | Oct. 4, 2014 | 08:02AM EST
  44. Salix Bails On Tax Inversion

    IBD | Oct. 3, 2014 | 18:47PM EST
  45. Nasdaq, S&P 500 Aim For 50-Day Lines; Alexion Breaks Out

    IBD | Oct. 3, 2014 | 13:32PM EST
  46. Salix Cancels Tax Inversion, Opens Way For Buyers

    IBD | Oct. 3, 2014 | 11:11AM EST
  47. Stocks Open Higher On Jobs Data; Mylan, Salix, Mobileye Climb

    IBD | Oct. 3, 2014 | 10:39AM EST
  48. Jobs Data Boost Stock Futures; Salix, Tekmira, Iamgold Rising

    IBD | Oct. 3, 2014 | 09:02AM EST
  49. SALIX PHARMACEUTICALS

    IBD | Oct. 2, 2014 | 18:45PM EST
  50. Top Fund Buys: Chipotle, Allergan, Jazz, Gilead

    IBD | Oct. 2, 2014 | 18:25PM EST
Trading Center